3 results
Approved WMOWill not start
The purpose of this study is to evaluate the possible risks and efficacy (improvement of disease) with an experimental oral study drug named eliglustat in pediatric patients from 2 to 18 years with Gaucher disease.
Approved WMOCompleted
To examine the effects of mono- and combination therapy with linagliptin and empagliflozine on renal hemodynamics
Approved WMOCompleted
To gain more knowledge about the effects of SGLT2 inhibition on renal hemodynamics and the underlying mechanisms.